This week, OpenAI announced a loosened partnership with Microsoft and an aggressive new strategy to secure computing power. We unpack what these updates signal about OpenAI’s business strategy and whether the company can scale while balancing a trial against Elon Musk and investor concerns over missed financial targets. Then, the A.I. researcher Dr. Adam Rodman, of Harvard Medical School, returns to tell us about the most significant ways A.I. is changing how doctors treat patients. And finally, can an LLM trained only on very old texts predict the future? We’re talking with one of the creators of the chatbot talkie.
Guests
-
Dr. Adam Rodman, internal medicine physician at Beth Israel Deaconess Medical Center and assistant professor at Harvard Medical School.
-
David Duvenaud, associate professor at the University of Toronto, former team lead at Anthropic and co-creator of talkie.
Additional Reading
Listen to and Follow ‘Hard Fork’
Apple | Spotify | Amazon | YouTube | iHeartRadio
Unlock full access to New York Times podcasts and explore everything from politics to pop culture. Subscribe today at nytimes.com/podcasts or on Apple Podcasts and Spotify.
Feedback
We want to hear from you. Email us at [email protected]. Find “Hard Fork” on YouTube and TikTok.
Credits
“Hard Fork” is hosted by Kevin Roose and Casey Newton and produced by Whitney Jones and Rachel Cohn. This episode was edited by Vjeran Pavic. Engineering by Daniel Ramirez and original music by Dan Powell, Marion Lozano, Diane Wong and Rowan Niemisto. Fact-checking by Caitlin Love.
Special thanks to Paula Szuchman, Pui-Wing Tam and Dahlia Haddad.
